GLP-1 receptor agonists: a magic bullet for obesity?

被引：0
|
作者：
不详
机构：
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2024年 / 51卷
关键词：
D O I：
10.1016/j.lanwpc.2024.101233
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [32] GLP-1 receptor agonists in heart failure
    Vaduganathan, Muthiah
    LANCET, 2024, 404 (10454): : 727 - 729
  • [33] GLP-1 receptor agonists in clinical practice
    Perez, Antonio
    MEDICINA CLINICA, 2024, 163 (05): : 242 - 244
  • [34] GI Effects of GLP-1 Receptor Agonists
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 191 - 192
  • [35] Novel GLP-1 receptor agonists for diabetes
    Garber, Alan J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (01) : 45 - 57
  • [36] The promise and hope of GLP-1 receptor agonists
    Sumithran, Priya
    Ard, Jamy
    LANCET DIABETES & ENDOCRINOLOGY, 2025, 13 (01): : 2 - 3
  • [37] Cardiovascular safety and GLP-1 receptor agonists
    Carty, David M.
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2013, 30 (06) : 242 - 245
  • [38] Variable Responses to GLP-1 Receptor Agonists
    Kunwar, Sandeep
    Samson, Kaeli
    Davis, Clifton
    Shivaswamy, Vijay
    Desouza, Cyrus
    DIABETES, 2022, 71
  • [39] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [40] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20
12345